SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bambusa Therapeutics Prices Upsized IPO at Midpoint, Raising About $169 Million

The clinical-stage biopharmaceutical company said it is selling shares. Its shares are set to begin trading Friday.

BBTX

Related stories